Back

Combined class I and class III antiarrhythmic effects of sotagliflozin - insights from heterologous expressions systems and atrial cardiomyocytes

1 September 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Novel insights into arrhythmias Ion Channels, Electrophysiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Leo Weirauch

Heidelberg (Germany)

8 More presentations in this session

Presentation thumbnail
Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8
Doctor D. Kukavica (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.
Doctor Q. Majid (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Advancing cardiac 3D organoid-on-chip: integrating iPSC-derived MELAS syndrome models to study electromechanical synchronicity and cardiac memory using contactless technology
Associate Professor M. Miragoli (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Investigating the role of WT1 in Brugada syndrome pathophysiology
Ms M. Marsman (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Computational modeling of cardiac electrophysiology applied to a swine model of Long QT Syndrome
Doctor A. Trancuccio (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into arrhythmias

The Event

Event poster

ESC Congress 2024

1 September 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation
thumbnail
Congress Presentation
SGLT2i and AF
thumbnail
Congress Presentation
New AADs: what's in the pipeline?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources